Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

PRMT6 Inhibitors (EPZ020411)

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical animal-model
PRMT6 drives hearing loss by promoting asymmetric arginine dimethylation-mediated FOXG1 degradation and suppressing mitophagy.
12-aug-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18